|Bid||0.00 x 3200|
|Ask||0.00 x 1800|
|Day's range||43.49 - 44.28|
|52-week range||40.94 - 61.71|
|Beta (5Y monthly)||0.65|
|PE ratio (TTM)||8.59|
|Earnings date||01 Nov 2022|
|Forward dividend & yield||1.60 (3.66%)|
|Ex-dividend date||03 Nov 2022|
|1y target est||56.81|
BMY's YTD performance indicates the stock has been a viable hedge against inflation because people can ill afford to cut back on health-focused spending.
Pfizer (PFE) closed the most recent trading day at $44.14, moving +0.87% from the previous trading session.
NEW YORK, October 03, 2022--Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the maker of NURTEC® ODT (rimegepant), an innovative migraine therapy approved for both acute treatment and prevention of episodic migraine in adults.